JUBILANT PHARMOVA
Back to Income Statement
|
JUBILANT PHARMOVA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹414 Cr | ₹836 Cr | ₹898 Cr | ₹574 Cr | ₹643 Cr |
What is the latest Consolidated Net Profit of JUBILANT PHARMOVA ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹414 Cr |
Mar2022 | ₹836 Cr |
Mar2021 | ₹898 Cr |
Mar2020 | ₹574 Cr |
Mar2019 | ₹643 Cr |
How is Consolidated Net Profit of JUBILANT PHARMOVA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹414 Cr | -50.48 | |
Mar2022 | ₹836 Cr | -6.94 | |
Mar2021 | ₹898 Cr | 56.36 | |
Mar2020 | ₹574 Cr | -10.63 | |
Mar2019 | ₹643 Cr | - |
Compare Consolidated Net Profit of peers of JUBILANT PHARMOVA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JUBILANT PHARMOVA | ₹10,769.5 Cr | -0.1% | 18.9% | 123.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
JUBILANT PHARMOVA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JUBILANT PHARMOVA | -0.1% |
18.9% |
123.2% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses